002821 凯莱英
已收盘 07-10 15:00:00
资讯
新帖
简况
创新药板块午后拉升,创新药ETF天弘(517380)上涨1.35%,年内涨超30%,居行业ETF第一
格隆汇 · 07-04
创新药板块午后拉升,创新药ETF天弘(517380)上涨1.35%,年内涨超30%,居行业ETF第一
港股创新药午后持续拉升荣昌生物涨超16%君实生物涨超7%凯莱英涨超5%昭衍新药、中国生物制药纷纷上扬。
智通财经 · 07-04
港股创新药午后持续拉升荣昌生物涨超16%君实生物涨超7%凯莱英涨超5%昭衍新药、中国生物制药纷纷上扬。
【港股异动 | CRO概念股持续走高 新药临床试验加速利好CRO企业 机构称板块补涨动力充足】智通财经APP获悉,CRO
智通财经 · 06-30
【港股异动 | CRO概念股持续走高 新药临床试验加速利好CRO企业 机构称板块补涨动力充足】智通财经APP获悉,CRO
【创新药板块探底回升,昭衍新药涨停】创新药板块探底回升,昭衍新药涨停,艾迪药业涨超6%,泰格医药、凯莱英、舒泰神跟涨。
金融界 · 06-30
【创新药板块探底回升,昭衍新药涨停】创新药板块探底回升,昭衍新药涨停,艾迪药业涨超6%,泰格医药、凯莱英、舒泰神跟涨。
凯莱英:2025年第一季度实现营业收入15.41亿
证券之星 · 06-24
凯莱英:2025年第一季度实现营业收入15.41亿
【摩根大通增持凯莱英(06821.HK)10.36万股 每股作价约75.34港元】智通财经APP获悉,香港联交所最新资料
智通财经 · 06-20
【摩根大通增持凯莱英(06821.HK)10.36万股 每股作价约75.34港元】智通财经APP获悉,香港联交所最新资料
摩根大通增持凯莱英(06821)10.36万股 每股作价约75.34港元
智通财经网 · 06-20
摩根大通增持凯莱英(06821)10.36万股 每股作价约75.34港元
凯莱英(06821.HK)获Norges Bank增持17.37万股
格隆汇 · 06-15
凯莱英(06821.HK)获Norges Bank增持17.37万股
Norges Bank增持凯莱英(06821)17.37万股 每股作价约77.93港元
智通财经 · 06-13
Norges Bank增持凯莱英(06821)17.37万股 每股作价约77.93港元
凯莱英(06821)将于7月25日派发末期股息每10股12.021592港元
智通财经 · 06-11
凯莱英(06821)将于7月25日派发末期股息每10股12.021592港元
凯莱英(06821)6月5日授出A股限制性股票合共427.33万股
智通财经 · 06-05
凯莱英(06821)6月5日授出A股限制性股票合共427.33万股
摩根大通减持凯莱英(06821)约1.19万股 每股作价约72.57港元
智通财经 · 06-04
摩根大通减持凯莱英(06821)约1.19万股 每股作价约72.57港元
每周股票复盘:凯莱英(002821)完成1,680股限制性股票回购注销
证券之星 · 05-30
每周股票复盘:凯莱英(002821)完成1,680股限制性股票回购注销
凯莱英涨5.68%,华安证券一个月前给出“买入”评级
证券之星 · 05-29
凯莱英涨5.68%,华安证券一个月前给出“买入”评级
凯莱英(06821.HK)获Schroders PLC增持16.86万股
格隆汇 · 05-28
凯莱英(06821.HK)获Schroders PLC增持16.86万股
青蒿素概念28日主力净流出5589.18万元,凯莱英、润都股份居前
金融界 · 05-28
青蒿素概念28日主力净流出5589.18万元,凯莱英、润都股份居前
中证500医药卫生指数上涨1.09%,前十大权重包含凯莱英等
金融界 · 05-27
中证500医药卫生指数上涨1.09%,前十大权重包含凯莱英等
Schroders PLC增持凯莱英(06821)33.93万股 每股作价约68.03港元
智通财经 · 05-27
Schroders PLC增持凯莱英(06821)33.93万股 每股作价约68.03港元
Norges Bank减持凯莱英(06821)25.63万股 每股作价约68.37港元
智通财经 · 05-27
Norges Bank减持凯莱英(06821)25.63万股 每股作价约68.37港元
凯莱英收盘下跌1.43%,滚动市盈率30.92倍,总市值307.26亿元
金融界 · 05-26
凯莱英收盘下跌1.43%,滚动市盈率30.92倍,总市值307.26亿元
加载更多
公司概况
公司名称:
凯莱英医药集团(天津)股份有限公司
所属行业:
医药制造业
上市日期:
2016-11-18
主营业务:
凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是临床阶段CDMO解决方案、商业化阶段CDMO解决方案、新兴服务。
发行价格:
30.53
{"stockData":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":88.64,"timestamp":1752131019000,"preClose":88.27,"halted":0,"volume":4714632,"delay":0,"changeRate":0.0042,"floatShares":317000000,"shares":361000000,"eps":2.7555,"marketStatus":"已收盘","change":0.37,"latestTime":"07-10 15:00:00","open":87.9,"high":91.83,"low":87.81,"amount":424000000,"amplitude":0.0455,"askPrice":88.65,"askSize":71,"bidPrice":88.64,"bidSize":7,"shortable":0,"etf":0,"ttmEps":2.7555,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752197400000},"marketStatusCode":5,"adr":0,"adjPreClose":88.27,"symbolType":"stock","openAndCloseTimeList":[[1752111000000,1752118200000],[1752123600000,1752130800000]],"highLimit":97.1,"lowLimit":79.44,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":360593720,"isCdr":false,"pbRate":1.85,"roa":"--","peRate":32.16839,"roe":"1.92%","epsLYR":2.69,"committee":0.079812,"marketValue":31963000000,"turnoverRate":0.0149,"status":0,"hkstockBrief":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":78.75,"timestamp":1752134894034,"preClose":78.75,"halted":0,"volume":444100,"delay":0,"premium":"-18.73"},"floatMarketCap":28100000000},"requestUrl":"/m/hq/s/002821","defaultTab":"news","newsList":[{"id":"2548351243","title":"创新药板块午后拉升,创新药ETF天弘(517380)上涨1.35%,年内涨超30%,居行业ETF第一","url":"https://stock-news.laohu8.com/highlight/detail?id=2548351243","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548351243?lang=zh_cn&edition=full","pubTime":"2025-07-04 14:06","pubTimestamp":1751609203,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159217","BK1583","BK4550","CXO","399441","BK1100","LU1064131003.USD","161726","09996","688180","HSCEI","BK7504","BK1191","159883","BK1161","BK1574","01877","09939","LU2328871848.SGD","LU2488822045.USD","HSTECH","BK0132","06978","515120","BK1222","159992","YANG","BK7095","06821","BK0239","BK1515","09995","159646","07226","002821","159938","BK4588","LU1328615791.USD","512290","BK4614","159859","159982","399300","688331","CXO.AU","FDN","LU1969619763.USD","LU2148510915.USD","09997"],"gpt_icon":0},{"id":"2548235931","title":"港股创新药午后持续拉升荣昌生物涨超16%君实生物涨超7%凯莱英涨超5%昭衍新药、中国生物制药纷纷上扬。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548235931","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548235931?lang=zh_cn&edition=full","pubTime":"2025-07-04 13:17","pubTimestamp":1751606276,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BZ08YT58.USD","BK0216","LU2328871848.SGD","BK1141","LU1328615791.USD","01177","BK1576","01877","688331","07226","LU1064130708.USD","IE00BZ08YR35.GBP","BK1583","603127","06127","BK1191","IE00BZ08YS42.EUR","YANG","09995","688180","LU2488822045.USD","BK1521","LU2148510915.USD","LU1969619763.USD","BK0132","BK1515","BK4614","BK1161","BK1574","06821","HSTECH","002821","06978","159992","LU1064131003.USD","HSCEI","BK0239","BK1589"],"gpt_icon":0},{"id":"2547030258","title":"【港股异动 | CRO概念股持续走高 新药临床试验加速利好CRO企业 机构称板块补涨动力充足】智通财经APP获悉,CRO","url":"https://stock-news.laohu8.com/highlight/detail?id=2547030258","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547030258?lang=zh_cn&edition=full","pubTime":"2025-06-30 11:23","pubTimestamp":1751253800,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0028","LU0348735423.USD","BK0239","LU1720050803.USD","LU1146622755.USD","03347","BK1141","LU0181495838.USD","LU0856984785.SGD","LU1880383366.USD","LU0516423174.USD","LU0823426308.USD","02269","BK1589","LU0039217434.USD","BK0077","06821","LU0043850808.USD","LU0320764599.SGD","LU0359201612.USD","LU0516422440.USD","LU0052750758.USD","LU1242518931.SGD","BK0216","BK1191","LU0359202008.SGD","LU0979878070.USD","LU1328615791.USD","LU0516423091.SGD","LU0417516738.SGD","LU0327786744.USD","LU0140636845.USD","LU0326950275.SGD","LU0819121731.USD","BK1521","LU0823426480.USD","LU0456827905.SGD","IE00B0JY6N72.USD","06127","603127","LU0417516902.SGD","BK1576","LU0516422366.SGD","LU0456846285.SGD","LU0708995583.HKD","LU0051755006.USD","300347","002821","BK1583","LU1688375341.USD"],"gpt_icon":0},{"id":"2547030203","title":"【创新药板块探底回升,昭衍新药涨停】创新药板块探底回升,昭衍新药涨停,艾迪药业涨超6%,泰格医药、凯莱英、舒泰神跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2547030203","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547030203?lang=zh_cn&edition=full","pubTime":"2025-06-30 11:21","pubTimestamp":1751253664,"startTime":"0","endTime":"0","summary":"创新药板块探底回升,昭衍新药涨停,艾迪药业涨超6%,泰格医药、凯莱英、舒泰神跟涨。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/30112151382528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1328615791.USD","BK0262","BK1576","300347","06978","BK0046","BK0077","BK0132","603127","BK0174","BK1161","688488","BK1191","BK0216","002821","BK1141","LU1146622755.USD","BK0239","300204","03347","BK1574","159992","BK0028","06127","06821","BK1583","LU1820825898.SGD"],"gpt_icon":0},{"id":"2545421860","title":"凯莱英:2025年第一季度实现营业收入15.41亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2545421860","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545421860?lang=zh_cn&edition=full","pubTime":"2025-06-24 08:40","pubTimestamp":1750725625,"startTime":"0","endTime":"0","summary":"证券之星消息,凯莱英(002821)06月23日在投资者关系平台上答复投资者关心的问题。投资者提问:请问为何一季度小分子业务收入没有增长了?凯莱英回复:尊敬的投资者,您好!公司2025年第一季度实现营业收入15.41亿,同比增长10.1%。其中小分子CDMO业务收入同比持平,新兴业务收入增长同步超80%。公司第一季度新签订单中小分子订单保持稳定增长,新兴业务新签订单展现出强劲增长态势。以上为实现2025年收入恢复到双位数增长奠定基础,公司对完成全年指引有信心。感谢关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062400006578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","002821"],"gpt_icon":0},{"id":"2544121580","title":"【摩根大通增持凯莱英(06821.HK)10.36万股 每股作价约75.34港元】智通财经APP获悉,香港联交所最新资料","url":"https://stock-news.laohu8.com/highlight/detail?id=2544121580","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544121580?lang=zh_cn&edition=full","pubTime":"2025-06-20 18:56","pubTimestamp":1750417000,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BDRTCR15.USD","LU0070302665.USD","LU2237443465.HKD","LU1670628061.USD","002821","LU0683600562.USD","LU2505996509.AUD","LU2023250843.SGD","IE00BLSP4452.SGD","06821","LU2213496289.HKD","IE000M9KFDE8.USD","BK4581","LU0417517546.SGD","BK4550","LU2456880835.USD","IE00BFXG1179.USD","LU0345770308.USD","LU1496350502.SGD","LU1974910355.USD","LU2237443622.USD","LU0820562030.AUD","IE00B775SV38.USD","LU2746668461.USD","BK4534","LU0868494708.USD","IE00BJTD4N35.SGD","LU1244550221.USD","IE00BZ1G4Q59.USD","LU0234572021.USD","LU2552382058.USD","LU1145028129.USD","LU0868494617.USD","BK4588","LU2357305700.SGD","LU1162221912.USD","IE00BLSP4239.USD","LU0238689110.USD","IE00BKVL7J92.USD","LU0820561909.HKD","LU1668664300.SGD","LU1267930490.SGD","LU1261432733.SGD","IE00BN8TJ469.HKD","IE00BWXC8680.SGD","LU2417539215.USD","IE00BHPRN162.USD","LU1629891620.HKD","IE00B1BXHZ80.USD","LU2054465674.USD"],"gpt_icon":0},{"id":"2544124571","title":"摩根大通增持凯莱英(06821)10.36万股 每股作价约75.34港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544124571","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544124571?lang=zh_cn&edition=full","pubTime":"2025-06-20 18:56","pubTimestamp":1750416960,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示,6月17日,摩根大通增持凯莱英(06821)10.36万股,每股作价75.3412港元,总金额约780.53万港元。增持后最新持股数目约为139.67万股,最新持股比例为5.06%。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-06-20/doc-infatrki2644317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999002224.SGD","LU2756315318.SGD","LU0203347892.USD","LU0689472784.USD","LU0211327993.USD","LU0170899867.USD","LU0251132253.USD","LU2505996509.AUD","LU0048584097.USD","LU1084165304.USD","LU2552382132.HKD","LU1551013425.SGD","LU1551013342.USD","LU0820562030.AUD","LU1670627923.USD","BK4516","BK4504","LU0964807845.USD","LU1244550494.USD","IE00B3S45H60.SGD","LU1244550221.USD","LU2237443465.HKD","LU1363072403.SGD","002821","LU0683600562.USD","IE00BJLML261.HKD","LU0215105999.USD","LU0496365809.HKD","IE00BZ1G4Q59.USD","LU2106854487.HKD","LU2462157665.USD","BK0132","LU2237443895.HKD","LU0211328371.USD","LU2237443549.SGD","LU2242649171.HKD","IE0034235188.USD","LU0943347566.SGD","LU2552382215.SGD","LU1267930490.SGD","LU0238689110.USD","LU1119994496.HKD","BK4566","LU0323591593.USD","LU2237443382.USD","06821","LU1162221912.USD","IE00BLSP4239.USD","LU0820561818.USD","LU1244550577.SGD"],"gpt_icon":0},{"id":"2543614140","title":"凯莱英(06821.HK)获Norges Bank增持17.37万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2543614140","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543614140?lang=zh_cn&edition=full","pubTime":"2025-06-16 06:56","pubTimestamp":1750028184,"startTime":"0","endTime":"0","summary":"格隆汇6月16日丨根据联交所最新权益披露资料显示,2025年6月11日,凯莱英(06821.HK)获Norges Bank在场内以每股均价77.9348港元增持17.37万股,涉资约1353.73万港元。增持后,Norges Bank最新持股数目为375.44万股,持股比例由12.99%上升至13.63%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/16065651083938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0132","LU1328615791.USD","002821","06821","BK0239","BK1191"],"gpt_icon":0},{"id":"2543689864","title":"Norges Bank增持凯莱英(06821)17.37万股 每股作价约77.93港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543689864","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543689864?lang=zh_cn&edition=full","pubTime":"2025-06-13 19:10","pubTimestamp":1749813009,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,6月11日,Norges Bank增持凯莱英(06821)17.37万股,每股作价为77.9348港元,总金额约为1353.73万港元。增持后最新持股数目为375.44万股,最新持股比例为13.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1305138.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","BK0239","LU1328615791.USD","BK0132","BK1191","002821"],"gpt_icon":0},{"id":"2542858736","title":"凯莱英(06821)将于7月25日派发末期股息每10股12.021592港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542858736","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542858736?lang=zh_cn&edition=full","pubTime":"2025-06-11 21:15","pubTimestamp":1749647732,"startTime":"0","endTime":"0","summary":"智通财经APP讯,凯莱英(06821)发布公告,将于2025年7月25日派发截至2024年12月31日止年度的末期股息每10股12.021592港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1304138.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","LU1328615791.USD","BK1191","BK0239","002821","BK0132"],"gpt_icon":0},{"id":"2541464024","title":"凯莱英(06821)6月5日授出A股限制性股票合共427.33万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2541464024","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541464024?lang=zh_cn&edition=full","pubTime":"2025-06-05 18:52","pubTimestamp":1749120772,"startTime":"0","endTime":"0","summary":"智通财经APP讯,凯莱英(06821)发布公告,于2025年6月5日授出A股限制性股票合共427.33万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1301814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","399300","BK0132","002821","BK1191","LU1328615791.USD","BK0239","159982"],"gpt_icon":0},{"id":"2540068948","title":"摩根大通减持凯莱英(06821)约1.19万股 每股作价约72.57港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540068948","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540068948?lang=zh_cn&edition=full","pubTime":"2025-06-04 19:11","pubTimestamp":1749035468,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,5月29日,摩根大通减持凯莱英(06821)1.19万股,每股作价72.5684港元,总金额约86.08万港元。减持后最新持股数目约为164.17万股,最新持股比例为5.95%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1301297.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4566","LU1162221912.USD","LU0820561818.USD","LU1267930490.SGD","LU2237443549.SGD","LU2054465674.USD","LU2237443382.USD","LU2023250843.SGD","IE00BBT3K403.USD","BK4533","LU0345770993.USD","LU1280957306.USD","IE00B1XK9C88.USD","LU1551013425.SGD","002821","LU1363072403.SGD","LU1366192091.USD","LU1974910355.USD","LU0211326755.USD","BK0132","LU0208291251.USD","LU0238689110.USD","SG9999002232.USD","LU2552382215.SGD","LU0203347892.USD","LU0640476718.USD","LU0820561909.HKD","LU1145028129.USD","LU0267386448.USD","LU0345769631.USD","LU2213496289.HKD","LU0070302665.USD","LU1988902786.USD","LU2746668461.USD","LU2237443622.USD","SG9999002224.SGD","IE00BJLML261.HKD","LU0211331839.USD","LU1328615791.USD","BK4534","LU0256863811.USD","LU1668664300.SGD","LU2023250504.SGD","LU2357305700.SGD","06821","BK4207","LU1670628061.USD","LU0868494708.USD","LU0320765646.SGD","LU2237443895.HKD"],"gpt_icon":0},{"id":"2539272797","title":"每周股票复盘:凯莱英(002821)完成1,680股限制性股票回购注销","url":"https://stock-news.laohu8.com/highlight/detail?id=2539272797","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539272797?lang=zh_cn&edition=full","pubTime":"2025-05-31 02:42","pubTimestamp":1748630560,"startTime":"0","endTime":"0","summary":"截至2025年5月30日收盘,凯莱英报收于94.23元,较上周的86.45元上涨9.0%。本周,凯莱英5月30日盘中最高价报96.3元,股价触及近一年最高点。本周关注点公司公告汇总: 凯莱英完成1,680股限制性股票回购注销公司公告汇总凯莱英医药集团完成了1名2020年限制性股票激励计划预留授予离职激励对象孙学惠持有的1,680股A股限制性股票的回购注销,占公司回购注销前A+H总股本360,595,400股的0.0005%,回购价格为102.46元/股,总计支付回购款172,132.80元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025053100004550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","BK0239","LU1328615791.USD","BK0132","BK1191","002821"],"gpt_icon":0},{"id":"2539232907","title":"凯莱英涨5.68%,华安证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2539232907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539232907?lang=zh_cn&edition=full","pubTime":"2025-05-29 16:31","pubTimestamp":1748507518,"startTime":"0","endTime":"0","summary":"今日凯莱英涨5.68%,收盘报93.1元。2025年4月26日,华安证券研究员谭国超,杨馥瑗发布了对凯莱英的研报《一季报业绩表现亮眼,新兴业务快速增长》,该研报对凯莱英给出“买入”评级。维持“买入”评级。此外,平安证券研究员倪亦道,叶寅,财信证券研究员吴号近期也对该股发布了研报,同样给出“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为民生证券的乔波耀。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052900024428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","06821","600909"],"gpt_icon":0},{"id":"2539173407","title":"凯莱英(06821.HK)获Schroders PLC增持16.86万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2539173407","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539173407?lang=zh_cn&edition=full","pubTime":"2025-05-29 06:46","pubTimestamp":1748472379,"startTime":"0","endTime":"0","summary":"格隆汇5月29日丨根据联交所最新权益披露资料显示,2025年5月27日,凯莱英(06821.HK)获Schroders PLC在场内以每股均价68.1482港元增持16.86万股,涉资约1149万港元。增持后,Schroders PLC最新持股数目为588.63万股,持股比例由20.75%上升至21.36%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/29064650729533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06821","BK1191","BK0239","LU1328615791.USD","BK0132","002821"],"gpt_icon":0},{"id":"2538447335","title":"青蒿素概念28日主力净流出5589.18万元,凯莱英、润都股份居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2538447335","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538447335?lang=zh_cn&edition=full","pubTime":"2025-05-28 15:41","pubTimestamp":1748418112,"startTime":"0","endTime":"0","summary":"5月28日,青蒿素概念下跌0.39%,今日主力资金流出5589.18万元,概念股3只上涨,8只下跌。主力资金净流出居前的分别为凯莱英、润都股份、昆药集团、海正药业、新和成。序号代码名称最新价涨跌幅主力净流入主力净占比1600216浙江医药14.161.224738.36万元7.8%2000593德龙汇能5.68-1.05306.24万元2.77%3600062华润双鹤19.05-0.162.47万元0.68%4603880南卫股份5.442.2651.98万元1.23%5600332白云山26.77-0.37-90.45万元-1.36%6600196复星医药23.53-0.42-256.55万元-1.82%7002001新 和 成21.88-0.45-1428.43万元-5.27%8600267海正药业8.99-1.21-1583.68万元-15.37%9600422昆药集团16.140.19-1727.41万元-18.23%10002923润都股份12.35-3.36-1735.71万元-12.26%","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/28154150710893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","LU1328615791.USD","002821","BK0239","002923","BK0132","06821"],"gpt_icon":0},{"id":"2538460046","title":"中证500医药卫生指数上涨1.09%,前十大权重包含凯莱英等","url":"https://stock-news.laohu8.com/highlight/detail?id=2538460046","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538460046?lang=zh_cn&edition=full","pubTime":"2025-05-27 23:08","pubTimestamp":1748358514,"startTime":"0","endTime":"0","summary":"金融界5月27日消息,上证指数低开震荡,中证500医药卫生指数 上涨1.09%,报9958.42点,成交额134.08亿元。数据统计显示,中证500医药卫生指数近一个月上涨3.48%,近三个月上涨1.02%,年至今上涨2.53%。从中证500医药卫生指数持仓样本的行业来看,医药卫生占比100.00%。在样本公司有特殊事件发生,导致其行业归属发生变更时,将对中证500行业指数样本进行相应调整。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/27230850696360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0132","000905.SH","BK1191","06821","159982","BK0239","000001.SH","LU1328615791.USD","399905","002821"],"gpt_icon":0},{"id":"2538468415","title":"Schroders PLC增持凯莱英(06821)33.93万股 每股作价约68.03港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538468415","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538468415?lang=zh_cn&edition=full","pubTime":"2025-05-27 18:58","pubTimestamp":1748343484,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,5月23日,Schroders PLC增持凯莱英(06821)33.93万股,每股作价68.026港元,总金额约为2308.12万港元。增持后最新持股数目为562.55万股,最新持股比例为20.42%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1298170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002821","BK1191","BK0132","06821","LU1328615791.USD"],"gpt_icon":0},{"id":"2538468419","title":"Norges Bank减持凯莱英(06821)25.63万股 每股作价约68.37港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538468419","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538468419?lang=zh_cn&edition=full","pubTime":"2025-05-27 18:57","pubTimestamp":1748343440,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,5月23日,Norges Bank减持凯莱英(06821)25.63万股,每股作价为68.3651港元,总金额约为1752.2万港元。减持后最新持股数目为342.47万股,最新持股比例为12.43%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1298165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002821","BK0132","LU1328615791.USD","06821","BK0239","BK1191"],"gpt_icon":0},{"id":"2538750931","title":"凯莱英收盘下跌1.43%,滚动市盈率30.92倍,总市值307.26亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538750931","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538750931?lang=zh_cn&edition=full","pubTime":"2025-05-26 16:56","pubTimestamp":1748249793,"startTime":"0","endTime":"0","summary":"5月26日,凯莱英今日收盘85.21元,下跌1.43%,滚动市盈率PE达到30.92倍,总市值307.26亿元。从行业市盈率排名来看,公司所处的医疗服务行业市盈率平均38.60倍,行业中值41.85倍,凯莱英排名第22位。资金流向方面,5月26日,凯莱英主力资金净流出4246.25万元,近5日总体呈流入状态,5日共流入7711.75万元。最新一期业绩显示,2025年一季报,公司实现营业收入15.41亿元,同比10.10%;净利润3.27亿元,同比15.83%,销售毛利率42.54%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/26165650658068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1328615791.USD","002821","BK0239","06821","BK0132","BK1191"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752164750068,"stockEarnings":[{"period":"1week","weight":-0.0055},{"period":"1month","weight":-0.049},{"period":"3month","weight":0.3793},{"period":"6month","weight":0.2879},{"period":"1year","weight":0.4574},{"period":"ytd","weight":0.1801}],"compareEarnings":[{"period":"1week","weight":0.014},{"period":"1month","weight":0.0369},{"period":"3month","weight":0.0838},{"period":"6month","weight":0.1077},{"period":"1year","weight":0.194},{"period":"ytd","weight":0.0471}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"凯莱英医药集团(天津)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2016-11-18","address":"天津市滨海新区经济技术开发区洞庭三街6号","registeredCapital":"36059万元","survey":" 凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是临床阶段CDMO解决方案、商业化阶段CDMO解决方案、新兴服务。","listedPrice":30.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,002821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}